Diabetes, Vol 42, Issue 10 1454-1461, Copyright © 1993 by American Diabetes Association

ARTICLES

Impaired vasodilator response to atrial natriuretic factor in IDDM

P Smits, FM Hersbach, TL Jansen, T Thien and JA Lutterman
Department of Medicine, University Hospital of Nijmegen, The Netherlands.

Diabetes mellitus has been associated with both elevated plasma concentrations of the natriuretic and vasorelaxant hormone atrial natriuretic factor and with a reduced natriuretic response to this hormone. We now hypothesize that the vasodilator response to atrial natriuretic factor is attenuated in IDDM. Forearm vasodilator responses to the infusion of six increasing dosages of atrial natriuretic factor into the brachial artery were registered by venous occlusion strain gauge plethysmography in 10 patients with uncomplicated IDDM and in 10 age-, sex-, and weight-matched control subjects. Baseline levels of blood pressure, forearm blood flow, and plasma concentrations of atrial natriuretic factor were not different between control subjects and patients with diabetes. In control subjects, atrial natriuretic factor induced a percentage fall in the forearm vascular resistance of -29 +/- 5% at the lowest to -72 +/- 4% at the highest infusion rate. In patients with diabetes this fall was significantly attenuated, measuring -2 +/- 7 and -45 +/- 4%, respectively, (P < 0.001 vs. control subjects). During infusion of atrial natriuretic factor into the brachial artery, the calculated regional production of cGMP (second messenger of atrial natriuretic factor) increased from 1.2 +/- 1.1 to 22.8 +/- 4.8 pmol.min-1 x 100 ml-1 in the control subjects, whereas hardly any change occurred in the patients with diabetes (from -2.1 +/- 1.2 to 2.9 +/- 4.7 pmol.min-1 x 100 ml-1). Furthermore, both control and diabetic subjects demonstrated an equal forearm vasodilator response to increasing infusion rates of the control vasodilator sodium nitroprusside. We conclude that uncomplicated IDDM is associated with a specific reduction in the vascular responsiveness to atrial natriuretic factor.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Potthast, S. E. Abbey-Hosch, L. K. Antos, J. S. Marchant, M. Kuhn, and L. R. Potter Calcium-dependent Dephosphorylation Mediates the Hyperosmotic and Lysophosphatidic Acid-dependent Inhibition of Natriuretic Peptide Receptor-B/Guanylyl Cyclase-B J. Biol. Chem., November 19, 2004; 279(47): 48513 - 48519. [Abstract] [Full Text] [PDF]

				B. Capaldo, V. Guardasole, F. Pardo, M. Matarazzo, F. Di Rella, F. Numis, B. Merola, S. Longobardi, and L. Sacca Abnormal Vascular Reactivity in Growth Hormone Deficiency Circulation, January 30, 2001; 103(4): 520 - 524. [Abstract] [Full Text] [PDF]

				Y. Yano, A. Katsuki, E. C. Gabazza, K. Ito, M. Fujii, M. Furuta, K. Tuchihashi, H. Goto, K. Nakatani, Y. Hori, et al. Plasma Brain Natriuretic Peptide Levels in Normotensive Noninsulin-Dependent Diabetic Patients with Microalbuminuria J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2353 - 2356. [Abstract] [Full Text]

				G. M. Pieper Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction Hypertension, May 1, 1998; 31(5): 1047 - 1060. [Full Text] [PDF]

				S. Makimattila, A. Virkamaki, P.-H. Groop, J. Cockcroft, T. Utriainen, J. Fagerudd, and H. Yki-Jarvinen Chronic Hyperglycemia Impairs Endothelial Function and Insulin Sensitivity Via Different Mechanisms in Insulin-Dependent Diabetes Mellitus Circulation, September 15, 1996; 94(6): 1276 - 1282. [Abstract] [Full Text]

				K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, T. Horio, and J. Yoshikawa Possible Involvement of Phospholipase D and Protein Kinase C in Vascular Growth Induced by Elevated Glucose Concentration Hypertension, August 1, 1996; 28(2): 159 - 168. [Abstract] [Full Text]